RUNX1 and metabolic dysfunction-associated steatotic liver disease: The novelty of the present study lies in the analysis of the hepatic and jejunal mRNA abundance of RUNX1, a molecule related to angiogenesis, in a well-characterized cohort of women with MO and NAFLD.